Summary

As Global Payer Asset Head, you will play a pivotal leadership role in shaping global access, pricing, reimbursement, and evidence strategies for an innovative cell therapy portfolio. You will serve as a trusted strategic partner to cross-functional asset teams and executive leaders, ensuring payer perspectives are embedded throughout development and commercialization planning. This role is accountable for driving robust global payer strategies that optimize value for patients, healthcare systems, and UCB while supporting successful launches and long-term asset growth.

Job description

About the role

As Global Payer Asset Head, you will play a pivotal leadership role in shaping global access, pricing, reimbursement, and evidence strategies for an innovative cell therapy portfolio. You will serve as a trusted strategic partner to cross-functional asset teams and executive leaders, ensuring payer perspectives are embedded throughout development and commercialization planning. This role is accountable for driving robust global payer strategies that optimize value for patients, healthcare systems, and UCB while supporting successful launches and long-term asset growth.

Who you'll work with

You will work closely with the Vice President, Health Technology Assessment & Payers, global asset leaders, access and pricing experts, health economics professionals, evidence generation teams, and regional and local market access organizations. You will lead a matrixed payer sub-team and collaborate with internal and external stakeholders to ensure access considerations are integrated into key strategic decisions throughout the asset lifecycle.

What you'll do

Co-create long-term global asset strategy and lifecycle planning.
Lead global access, pricing, and payer evidence strategies.
Direct a high-performing cross-functional payer sub-team.
Shape value propositions through payer insights and market research.
Integrate payer requirements into evidence generation plans.
Support global launch readiness and access strategy execution.

Requirements

Advanced degree in life sciences, pharmacy, medicine, economics, or related field
8+ years in market access, pricing, health economics, or payer strategy
Experience developing global access and reimbursement strategies
Knowledge of U.S. and major international healthcare systems
Proven leadership in complex matrixed organizations
Strong communication, analytical, and strategic planning skills
PhD, PharmD, MD, MBA, or equivalent advanced qualification (preferred)
Experience supporting innovative therapies or specialty medicines (preferred)
Expertise in health technology assessment and reimbursement submissions (preferred)
Experience with payer evidence generation and health economic modeling (preferred)
Established network within payer, policy, or market access communities (preferred)
Demonstrated success influencing senior stakeholders globally (preferred)

Benefits

Hybrid work environment
Inclusive culture
Professional growth opportunities

Company overview

UCB is a global biopharmaceutical company headquartered in Brussels, Belgium, with a rich history dating back to 1928. The company specializes in developing innovative medicines for severe central nervous system and immunological conditions, with a particular focus on epilepsy, Parkinson's disease, and Crohn's disease. UCB operates in over 40 countries worldwide and employs approximately 9,378 people globally. The company's research and development efforts are centered on creating meaningful solutions that go beyond medicine, driven by patient experiences and scientific innovation. UCB's notable products include Keppra (levetiracetam) for epilepsy, Cimzia (certolizumab pegol) for autoimmune diseases, and Zyrtec (cetirizine) for allergies. With a strong commitment to sustainability and patient-centered care, UCB continues to advance transformative science and technologies to address unmet medical needs and improve the quality of life for patients worldwide.